DENTSPLY SIRONA Inc. $XRAY Shares Acquired by Fuller & Thaler Asset Management Inc.

Key Points

• Fuller & Thaler Asset Management Inc. increased its stake in DENTSPLY SIRONA by 4.7%, acquiring an additional 538,531 shares, making it 0.7% of their investment portfolio.
• Institutional investors own 95.70% of DENTSPLY SIRONA's stock, with several major firms, including Vanguard and AQR Capital Management, significantly increasing their holdings.
• DENTSPLY SIRONA reported a quarterly earnings per share of $0.52, slightly exceeding analysts' expectations, despite a 4.9% decrease in revenue compared to the previous year.

Fuller & Thaler Asset Management Inc. lifted its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 4.7% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 12,077,949 shares of the medical instruments supplier's stock after buying an additional 538,531 shares during the period. DENTSPLY SIRONA makes up 0.7% of Fuller & Thaler Asset Management Inc.'s investment portfolio, making the stock its 29th largest holding. Fuller & Thaler Asset Management Inc. owned about 6.06% of DENTSPLY SIRONA worth $180,445,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently modified their holdings of the stock. Quarry LP grew its position in DENTSPLY SIRONA by 25.7% during the 4th quarter. Quarry LP now owns 3,816 shares of the medical instruments supplier's stock worth $72,000 after purchasing an additional 780 shares during the last quarter. Colonial Trust Co SC purchased a new position in DENTSPLY SIRONA during the 4th quarter worth $26,000. Covestor Ltd grew its position in DENTSPLY SIRONA by 17.5% during the 1st quarter. Covestor Ltd now owns 9,778 shares of the medical instruments supplier's stock worth $146,000 after purchasing an additional 1,456 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. acquired a new stake in shares of DENTSPLY SIRONA in the 1st quarter worth $25,000. Finally, Principal Financial Group Inc. lifted its stake in shares of DENTSPLY SIRONA by 0.4% in the 1st quarter. Principal Financial Group Inc. now owns 457,397 shares of the medical instruments supplier's stock worth $6,834,000 after acquiring an additional 1,708 shares during the period. 95.70% of the stock is owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ XRAY traded up $0.76 during midday trading on Friday, hitting $14.66. The company had a trading volume of 2,284,098 shares, compared to its average volume of 3,007,447. The company has a quick ratio of 1.11, a current ratio of 1.69 and a debt-to-equity ratio of 1.13. DENTSPLY SIRONA Inc. has a twelve month low of $12.16 and a twelve month high of $27.48. The business has a 50-day simple moving average of $15.29 and a two-hundred day simple moving average of $15.55. The firm has a market capitalization of $2.92 billion, a price-to-earnings ratio of -3.09, a price-to-earnings-growth ratio of 0.89 and a beta of 0.94.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $0.52 EPS for the quarter, beating the consensus estimate of $0.50 by $0.02. The firm had revenue of $936.00 million during the quarter, compared to analysts' expectations of $929.67 million. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. The business's revenue for the quarter was down 4.9% compared to the same quarter last year. During the same quarter last year, the business earned $0.49 earnings per share. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. Equities research analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 10th. Shareholders of record on Friday, September 26th will be given a dividend of $0.16 per share. The ex-dividend date is Friday, September 26th. This represents a $0.64 dividend on an annualized basis and a yield of 4.4%. DENTSPLY SIRONA's payout ratio is presently -13.50%.

Analysts Set New Price Targets

XRAY has been the subject of several recent analyst reports. Wall Street Zen cut shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research note on Saturday, August 9th. UBS Group reduced their target price on shares of DENTSPLY SIRONA from $25.00 to $24.00 and set a "buy" rating for the company in a research note on Friday, August 8th. Needham & Company LLC restated a "hold" rating on shares of DENTSPLY SIRONA in a research note on Monday, July 21st. Piper Sandler reduced their target price on shares of DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating for the company in a research note on Wednesday, April 30th. Finally, Barrington Research reduced their target price on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set an "outperform" rating for the company in a research note on Friday, August 8th. Two investment analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. According to data from MarketBeat, DENTSPLY SIRONA presently has an average rating of "Hold" and a consensus price target of $18.64.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.